Nordicus Partners Corporation NORD

Q4 FY2025 · ended Mar 31, 2025 · Revenue $0, -100.0% YoY · Filed Jul 14, 2026

Nordicus Partners Corporation (NORD) files with the SEC under industry code 8742, Services-Management Consulting Services. Free cash flow was -$168,638.

Revenue
$0
-100.0% vs prior quarter
Net income
$-2.28M
-88.6% vs year-ago quarter
Operating cash flow
$-159,844
+62.5% vs year-ago quarter
Free cash flow
$-168,638
+75.1% vs prior quarter
EPS
$-0.13
-85.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
19.44M
+8.8% vs year-ago quarter
Net cash
—
Operating margin
-50612.4%
Q3 FY2025

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
NORD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1011060
Former names
EKIMAS Corp (until May 3, 2023); AdvanSource Biomaterials Corp (until Apr 3, 2020); CARDIOTECH INTERNATIONAL INC (until Sep 8, 2008)

Other Services-Management Consulting Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2027
Jun 30, 2026
Q4 FY2026
Mar 31, 2026
Q3 FY2026
Dec 31, 2025
Q2 FY2026
Sep 30, 2025
Q1 FY2026
Jun 30, 2025
Operating income
-$819,624
-$1.2M
-$1.1M
-$1.2M
-$831,886
Net income
-$2.3M
-$56,112
-$1.2M
-$1.5M
-$1.2M
Diluted EPS
-$0.13
-$0.00
-$0.07
-$0.08
-$0.07
Operating cash flow
-$159,844
-$675,076
-$1.5M
-$1.8M
-$425,698
Free cash flow
-$168,638
-$676,927
-$1.5M
-$1.8M
—
Total assets
$73.1M
$75.5M
$75.9M
$75.9M
$76.1M
Total liabilities
$11.6M
$11.2M
$11.1M
$11.2M
$11.9M
Stockholders' equity
$61.6M
$64.3M
$64.8M
$64.7M
$64.3M
Cash and investments
$768,784
$2.3M
$1.3M
$1.5M
$1.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Unregistered share sale
Nov 4, 2026 Nov 4, 2026
8-K Current report
Material agreement, New debt
Oct 21, 2026 Oct 21, 2026
8-K Current report
Material agreement, New debt
Oct 14, 2026 Oct 14, 2026
10-Q Quarterly report Sep 28, 2026 Jun 30, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 17, 2026 Sep 16, 2026
8-K Current report
Officer or director change
Sep 4, 2026 Sep 4, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.